Gencurix Inc. (KOSDAQ:229000)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,804.00
-11.00 (-0.61%)
Feb 18, 2025, 9:00 AM KST

Gencurix Revenue

Gencurix had revenue of 1.44B KRW in the quarter ending September 30, 2024, with 50.03% growth. This brings the company's revenue in the last twelve months to 3.39B, up 25.69% year-over-year. In the year 2023, Gencurix had annual revenue of 2.60B with 1.60% growth.

Revenue (ttm)
3.39B
Revenue Growth
+25.69%
P/S Ratio
8.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
31.39B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.60B40.83M1.60%
Dec 31, 20222.56B-487.46M-16.00%
Dec 31, 20213.05B1.47B93.83%
Dec 31, 20201.57B1.44B1,050.64%
Dec 31, 2019136.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,364.39B
Celltrion 2,876.25B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
SK bioscience 201.30B
Hanmi Pharm. 1,495.50B
Hanmi Science 1,283.65B
Hanall Biopharma 134.24B
Revenue Rankings